Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 07/23: (CARA) (SNDK) (CRUS) Higher; (CVA) (URI) (SCSS) Lower (more...)

July 23, 2015 9:30 AM
Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) 51% HIGHER; announced the Phase 3 development strategy of its lead glaucoma drug, trabodenoson, a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles